-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Chimerix (CMRX)
-
-
-
-
-
-
-
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Chimerix (CMRX) Receives FDA Orphan Drug Designation for Brincidofovir for Treatment of Smallpox
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

